+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Caspofungin Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129886
Global Caspofungin Market Size, Share & Trends Analysis Report By Infection Type (Candidiasis and Thrush), By Dosage Forms (Powders, Ointments, and Drugs), and Forecast 2020-2026
The global caspofungin market is anticipated to grow at a CAGR of around 5% during the forecast period. Caspofungin is used in the treatment of various bacterial infections. Additionally, caspofungin is also used in the treatment of infections in the internal body areas including the stomach, lungs, esophagus. Caspofungin belongs to the class of antifungals that is termed as the echinocandins. Caspofungin appears to have a lower incidence of adverse effects which is anticipated to contribute significantly to the growth of the caspofungin market.

The caspofungin market is segmented on the basis of the infection type and dosage form. Based on the infection type, the market is sub-segmented into candidiasis and thrush. The candidiasis segment is estimated to contribute prominent share over the forecast period. The segmental growth of the market is attributed to the increasing prevalence of esophageal candidiasis among men and vaginal yeast infections among women. Further based on the dosage forms, the market is sub-segmented into powders, ointments, and drugs.

Geographically, the study of the global caspofungin market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global caspofungin market during the forecast period. North America is expected to contribute a prominent share in the market. The growth in the region is due to the increased R&D activities to find the alternative of anti-fungal drugs for the patient that has developed resistance to the currently available one.

Some of the key players of the global caspofungin market include Athenex Inc., Fresenius SE & Co. KGaA, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., New Xellia Group A/S,Centrient Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and others.

Research Methodology

The market study of the global caspofungin market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the caspofungin manufacturers, pharmaceutical industry, drug manufacturing companies, active pharmaceutical ingredient manufacturers, hospitals& clinics, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Caspofungin Market Research and Analysis by Infection Type
2. Global Caspofungin Market Research and Analysis by Dosage Forms

The Report Covers
  • Comprehensive research methodology of the global caspofungin market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global caspofungin market.
  • Insights about market determinants which are stimulating the global caspofungin market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. AthenexInc. Overview Financial Analysis SWOT Analysis Recent Developments
3.2.2. Merck & Co. Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.2.3. Fresenius SE & Co. KGaA Overview Financial Analysis SWOT Analysis Recent Developments
3.2.4. New Xellia Group A/S Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Caspofungin Market by Infection Type
5.1.1. Candidiasis
5.1.2. Thrush
5.2. Global Caspofungin Market by Dosage Forms
5.2.1. Powders
5.2.2. Ointments
5.2.3. Drugs
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Altan Pharma Ltd.
7.2. Alvogen
7.3. Centrient Pharmaceuticals
7.4. Cipla Ltd.
7.5. Fresenius SE & Co. KGaA
7.6. LivealthBioPharma Pvt. Ltd.
7.7. MDA Inc.
7.8. Merck & Co. Inc.
7.9. Mylan NV
7.10. New Xellia Group A/S
7.11. ParchemFine &Specialty Chemicals
7.12. Pfizer Inc.
7.13. Rewine Pharmaceutical
7.14. Sanofi SA
7.15. Stanex Drugs and Chemicals Pvt. Ltd.
7.16. Sun Pharmaceutical Industries Ltd.
7.17. SVAK Life Sciences
7.18. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Altan Pharma Ltd.
  • Alvogen
  • Centrient Pharmaceuticals
  • Cipla Ltd.
  • Fresenius SE & Co. KGaA
  • Livealth BioPharma Pvt. Ltd.
  • MDA Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • New Xellia Group A/S
  • ParchemFine &Specialty Chemicals
  • Pfizer Inc.
  • Rewine Pharmaceutical
  • Sanofi SA
  • Stanex Drugs and Chemicals Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • SVAK Life Sciences